Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breakthrough Cancer Pain”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT00105937
What this trial is testing

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

Who this might be right for
PainCancer
Cephalon 300
Not applicableUnknownNCT01693328
What this trial is testing

Patient Satisfaction and Quality of Life Impact - PecFent®

Who this might be right for
Breakthrough Cancer Pain
Archimedes Development Ltd 300
Not applicableStudy completedNCT00994760
What this trial is testing

Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

Who this might be right for
Breakthrough PainCancer
Takeda 131
Large-scale testing (Phase 3)Study completedNCT00684632
What this trial is testing

A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

Who this might be right for
Pain, Cancer
Kyowa Kirin Co., Ltd. 51
Not applicableStudy completedNCT02382653
What this trial is testing

Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain

Who this might be right for
Neoplasm Metastases
Tanta University 100
Large-scale testing (Phase 3)Study completedNCT01326689
What this trial is testing

A Comparative Study of KW-2246

Who this might be right for
Cancer Related Pain (Breakthrough Pain)
Kyowa Kirin Co., Ltd. 42
Post-approval studies (Phase 4)Ended earlyNCT01315886
What this trial is testing

Conversion From Fast Acting Oral Opioids to Abstral®

Who this might be right for
Pain
Orexo AB 8
Not applicableLooking for participantsNCT06287788
What this trial is testing

A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University 240
Large-scale testing (Phase 3)Study completedNCT00263575
What this trial is testing

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

Who this might be right for
PainCancer
Kyowa Kirin Co., Ltd. 139
Testing effectiveness (Phase 2)Ended earlyNCT02514252
What this trial is testing

Sublingual Fentanyl for the Management of Breakthrough Pain

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT01842893
What this trial is testing

Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer

Who this might be right for
Breakthrough PainCancer
Ethypharm 91
Testing effectiveness (Phase 2)Ended earlyNCT01439919
What this trial is testing

A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

Who this might be right for
PainBreakthrough Cancer Pain
Sanofi 5
Large-scale testing (Phase 3)Study completedNCT00236145
What this trial is testing

Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain

Who this might be right for
Breakthrough Pain
Cephalon
Not applicableStudy completedNCT03669263
What this trial is testing

A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan

Who this might be right for
Breakthrough Cancer Pain
Chang Gung Memorial Hospital 36
Testing effectiveness (Phase 2)UnknownNCT03564548
What this trial is testing

Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain

Who this might be right for
CancerBreakthrough Cancer Pain
Tetra Bio-Pharma 20
Not applicableStudy completedNCT01936636
What this trial is testing

Observational Registry Study of Quality of Life When Treating BTcP With Abstral

Who this might be right for
Quality of LifeBreakthrough Cancer Pain
Galena Biopharma, Inc. 164
Not applicableStudy completedNCT03435120
What this trial is testing

Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)

Who this might be right for
Breakthrough Pain
Angelini Farmacéutica 118
Testing effectiveness (Phase 2)Ended earlyNCT00351715
What this trial is testing

Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients

Who this might be right for
CancerPain
AHS Cancer Control Alberta 5
Not applicableStudy completedNCT01400854
What this trial is testing

Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability

Who this might be right for
CancerPain
Cephalon 600
Testing effectiveness (Phase 2)Study completedNCT00833040
What this trial is testing

The Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain

Who this might be right for
CancerPain
Talphera, Inc 34
Next Page